Document Detail


Synthesis and cytotoxic activity of some novel polycyclic gamma-butyrolactones.
MedLine Citation:
PMID:  18707881     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Baeyer-Villiger oxidation of 5-aryl-7,11,11-trimethyltricyclo[5.4.0.0(3,6)]-undec-1-en-4-ones 4a-h by H(2)O(2) and formic acid in methanol yields mixtures of 3b,7,7-trimethyl-3-phenyl-3,3a,3b,4,5,6,7,8a-octahydro-1H-indeno-[1,2-c]furan-1-ones 8a-h and 3b,7,7-trimethyl-3-phenyl-3,3a,3b,4,5,6,7,8a-octahydro-1H-indeno-[1,2-c]furan-2-ones 9a-h in high yields. The obtained butyrolactones 8a-h display cytotoxic activity against a number of human cancer cells.
Authors:
M P S Ishar; Tilak Raj; Satyam Kumar Agrawal; A K Saxena; Lakhwinder Singh; Rajinder Singh; Surinderjit Singh Bhella
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-07-27
Journal Detail:
Title:  Bioorganic & medicinal chemistry letters     Volume:  18     ISSN:  1464-3405     ISO Abbreviation:  Bioorg. Med. Chem. Lett.     Publication Date:  2008 Sep 
Date Detail:
Created Date:  2008-08-29     Completed Date:  2008-10-27     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9107377     Medline TA:  Bioorg Med Chem Lett     Country:  England    
Other Details:
Languages:  eng     Pagination:  4809-12     Citation Subset:  IM    
Affiliation:
Bio-Organic and Photochemistry Laboratory, Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab 143 005, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
4-Butyrolactone / analogs & derivatives,  chemical synthesis*,  toxicity*
Antineoplastic Agents / chemical synthesis,  toxicity
Cell Line, Tumor
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Female
Growth Inhibitors / chemical synthesis*,  toxicity
Humans
Male
Polycyclic Compounds / chemical synthesis*,  toxicity*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Growth Inhibitors; 0/Polycyclic Compounds; 96-48-0/4-Butyrolactone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Aglycone exploration of C-arylglucoside inhibitors of renal sodium-dependent glucose transporter SGL...
Next Document:  Evidences for complex formation between L-dabPNA and aegPNA.